23 May 2013
Keywords: epimmune, 1st-qtr, net, loss, rockets, usa-based, vaccine
Article | 30 May 2005
USA-based vaccine maker Epimmune saw its net loss for the first quarter of 2005 shoot up to $2.4 million, or $0.15 per share, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.